Skip to main content
. 2020 Apr 22;112(2):343–353. doi: 10.1093/ajcn/nqaa079

TABLE 3.

HRs (95% CIs) of Alzheimer disease and related dementias (ADRD) events over 26 y of follow-up based on a 5-y cutoff between ADRD diagnosis and updated flavonoid intake data1

Flavonoid intake percentile category
Flavonoid class ≤15th >15th to 30th >30th to 60th >60th P-trend2
Flavonols (n3 = 420/36) (n = 420/36) (n = 841/63) (n = 1120/58)
 Model 14 1.00 (ref.) 1.00 (0.62, 1.59) 0.89 (0.58, 1.36) 0.58 (0.37, 0.91) 0.004
 Model 25 1.00 (ref.) 0.96 (0.60, 1.56) 0.84 (0.54, 1.29) 0.51 (0.32, 0.82) 0.001
 Model 36 1.00 (ref.) 1.00 (0.61, 1.64) 0.85 (0.53, 1.35) 0.54 (0.32, 0.90) 0.003
Flavones (n = 420/31) (n = 420/21) (n = 841/47) (n = 1120/94)
 Model 14 1.00 (ref.) 0.75 (0.43, 1.31) 0.60 (0.38, 0.95) 0.86 (0.55, 1.32) 0.92
 Model 25 1.00 (ref.) 0.76 (0.44, 1.33) 0.57 (0.35, 0.91) 0.83 (0.53, 1.30) 0.99
 Model 36 1.00 (ref.) 0.83 (0.47, 1.46) 0.61 (0.38, 0.99) 0.92 (0.57, 1.48) 0.72
Flavanones (n = 418/26) (n = 422/20) (n = 840/38) (n = 1121/109)
 Model 14 1.00 (ref.) 0.62 (0.34, 1.11) 0.49 (0.30, 0.81) 0.88 (0.56, 1.37) 0.22
 Model 25 1.00 (ref.) 0.61 (0.34, 1.10) 0.48 (0.29, 0.80) 0.84 (0.53, 1.33) 0.32
 Model 36 1.00 (ref.) 0.66 (0.36, 1.20) 0.52 (0.31, 0.88) 0.92 (0.57, 1.49) 0.21
Flavan-3-ols (n = 419/33) (n = 422/36) (n = 840/49) (n = 1120/75)
 Model 14 1.00 (ref.) 1.13 (0.7, 1.83) 0.74 (0.47, 1.16) 0.77 (0.50, 1.20) 0.19
 Model 25 1.00 (ref.) 1.08 (0.66, 1.75) 0.66 (0.41, 1.06) 0.68 (0.44, 1.07) 0.09
 Model 36 1.00 (ref.) 1.03 (0.63, 1.70) 0.65 (0.40, 1.05) 0.69 (0.43, 1.09) 0.13
Anthocyanins (n = 420/49) (n = 421/32) (n = 840/65) (n = 1120/47)
 Model 14 1.00 (ref.) 0.52 (0.33, 0.82) 0.53 (0.36, 0.77) 0.29 (0.19, 0.45) <0.001
 Model 25 1.00 (ref.) 0.50 (0.32, 0.79) 0.53 (0.36, 0.78) 0.26 (0.16, 0.40) <0.001
 Model 36 1.00 (ref.) 0.48 (0.30, 0.77) 0.49 (0.32, 0.74) 0.24 (0.15, 0.39) <0.001
Flavonoid polymers (n = 420/33) (n = 420/34) (n = 840/57) (n = 1121/69)
 Model 14 1.00 (ref.) 0.90 (0.55, 1.47) 0.70 (0.45, 1.10) 0.60 (0.38, 0.95) 0.03
 Model 25 1.00 (ref.) 0.88 (0.54, 1.44) 0.63 (0.40, 1.00) 0.53 (0.33, 0.85) 0.008
 Model 36 1.00 (ref.) 0.88 (0.53, 1.46) 0.65 (0.40, 1.05) 0.58 (0.35, 0.94) 0.03
Total flavonoids (n = 419/27) (n = 421/30) (n = 841/61) (n = 1120/75)
 Model 14 1.00 (ref.) 0.96 (0.56, 1.63) 0.94 (0.58, 1.50) 0.78 (0.48, 1.27) 0.22
 Model 25 1.00 (ref.) 0.91 (0.53, 1.56) 0.86 (0.53, 1.39) 0.68 (0.41, 1.12) 0.08
 Model 36 1.00 (ref.) 0.89 (0.51, 1.55) 0.90 (0.54, 1.48) 0.73 (0.43, 1.24) 0.18
1

Mean follow-up time of 19.7 y.

2

P values for the test of linear trend across percentile categories were based on linear regression models with the median intake of each percentile category assigned to individuals with intake in that category, and this percentile median variable was used as a continuous measure in regression models.

3

n represents the number of participants/ADRD events per percentile category for model 1.

4

Model 1 adjusted for age, sex, education, apoE ε4 allele, and total energy intake; total n = 2801; n ADRD events = 193.

5

Model 2 adjusted for model 1 covariates + physical activity index, smoking status, BMI, prevalent stroke, diabetes, hypertension, and hypercholesterolemia; total n = 2797; n ADRD events = 189.

6

Model 3 adjusted for model 1 and model 2 covariates + overall dietary quality, vitamin and mineral supplement use, and dietary intakes of alcohol, ω-3 fatty acids (EPA and DHA), lutein, and zeaxanthin; total n = 2795; n ADRD events = 187.